Rani Therapeutics Holdings (RANI) Return on Equity (2021 - 2025)
Historic Return on Equity for Rani Therapeutics Holdings (RANI) over the last 5 years, with Q3 2025 value amounting to 4.51%.
- Rani Therapeutics Holdings' Return on Equity rose 142000.0% to 4.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.51%, marking a year-over-year increase of 142000.0%. This contributed to the annual value of 3.91% for FY2024, which is 25500.0% down from last year.
- As of Q3 2025, Rani Therapeutics Holdings' Return on Equity stood at 4.51%, which was up 142000.0% from 7.23% recorded in Q2 2025.
- Over the past 5 years, Rani Therapeutics Holdings' Return on Equity peaked at 58.77% during Q1 2025, and registered a low of 12.21% during Q4 2024.
- Moreover, its 5-year median value for Return on Equity was 0.98% (2023), whereas its average is 1.1%.
- In the last 5 years, Rani Therapeutics Holdings' Return on Equity plummeted by -99600bps in 2024 and then soared by 620700bps in 2025.
- Quarter analysis of 5 years shows Rani Therapeutics Holdings' Return on Equity stood at 0.42% in 2021, then tumbled by -88bps to 0.79% in 2022, then plummeted by -185bps to 2.25% in 2023, then crashed by -442bps to 12.21% in 2024, then soared by 137bps to 4.51% in 2025.
- Its last three reported values are 4.51% in Q3 2025, 7.23% for Q2 2025, and 58.77% during Q1 2025.